ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RVNC

NEW YORK, Jan. 9, 2022 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November 25, 2019 and October 11, 2021, inclusive (the “Class Period”), of the important February 8,…